UPDATE : Tuesday, October 15, 2019
Roche’s breast cancer drug gains more insurance benefits
The Ministry of Health and Welfare has granted additional reimbursement to ...
by Lee Han-soo  |  2019-05-21 10:44
Bridge Biotherapeutics releases first-in-human study for idiopathic pulmonary fibrosis treatment
Bridge Biotherapeutics announced that the company has presented interim dat...
by Lee Han-soo  |  2019-05-20 15:29
Saxenda's sales surge 3,000 times yoy in Q1
Novo Nordisk’s Saxenda (ingredient: liraglutide), an obesity treatment, is ...
by Lee Han-soo  |  2019-05-17 14:37
Daewoong launches Nabota in US amid controversy
Daewoong Pharmaceutical said it has officially launched Nabota, its botulin...
by Lee Han-soo  |  2019-05-16 16:33
Latecomer SGLT2 inhibitor Steglatro unlikely to get free ride
The Korean Diabetes Association (KDA)’s revised guideline for diabetes trea...
by Kim Yun-mi  |  2019-05-15 15:30
Keytruda wins nod as adjuvant therapy after melanoma surgery
The Ministry of Food and Drug Safety has approved PD-1 inhibitor immunother...
by Kim Yun-mi  |  2019-05-15 14:14
EU lists Korea on drug standard whitelist
Korea's medical export to the European Union is expected to see strong ...
by Lee Han-soo  |  2019-05-15 13:25
J&J's nasal spray depression treatment still met with some skepticism
Johnson & Johnson's Spravato (ingredient: esketamine), a new nasal spra...
by Lee Han-soo  |  2019-05-14 15:26
‘MSD Korea’s foreign exec got drunk, sexually harassed female worker’
A foreign executive at MSD Korea not only sexually harassed a female employ...
by Jeong Sae-im  |  2019-05-14 11:53
Korean companies excel multinational pharma’s R&D in investment-sales ratio
Local pharmaceutical companies surpassed multinational giants in research a...
by Lee Han-soo  |  2019-05-13 17:27
Chinese patients vaccinate MSD’s product in Korea. Why?
An increasing number of Chinese female patients are visiting Korean obstetr...
by Lee Han-soo  |  2019-05-13 14:57
US trade agency orders Daewoong to submit Nabota’s strain
The prolonged dispute between Medytox and Daewoong over the origin of Nabot...
by Lee Han-soo  |  2019-05-13 14:37
Antibody-drug conjugates on the rise as Herceptin’s patent to expire soon
With Roche’s HER2-positive breast cancer drug Herceptin (trastuzumab) facin...
by Kim Yun-mi  |  2019-05-13 14:23
Pfizer keeps lead over multinational pharmas in 2018 sales
Multinational pharmaceutical companies have shown mixed results in their sa...
by Lee Han-soo  |  2019-05-10 17:17
Xeljianz is easier to use than biologic therapies -- is it safer, however?
Pfizer’s Xeljianz (tofacitinib), an oral Janus kinase (JAK) inhibitor to tr...
by Kim Yun-mi  |  2019-05-10 15:34
[Exclusive] MSD Korea playing tricks to reduce daycare cost
Korea Biomedical Review ran an exclusive story on an executive at MSD Korea...
by Kim Yun-mi  |  2019-05-09 11:20
T&R Biofab, CiSTEM to co-develop rare disease treatments
T&R Biofab and CiSTEM have signed a technology transfer contract to develop...
by Lee Han-soo  |  2019-05-09 11:17
‘GC Wellbeing’s placenta injection has liver regenerative effects’
GC Wellbeing, a subsidiary of GC, has released the results of a study regar...
by Lee Han-soo  |  2019-05-08 17:07
Celgene’s myelodysplastic syndrome treatment gets more insurance benefits
The Ministry of Health and Welfare has granted additional reimbursement to ...
by Lee Han-soo  |  2019-05-07 17:36
GC Cell to start developing CAR-T treatment for pancreatic cancer
GC Cell has concluded a material transfer agreement with Mogam Institute fo...
by Lee Han-soo  |  2019-05-07 16:10
Back to Top